Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Antidepressant effects of TNF-α blockade in an animal model of depression.

Krügel U, Fischer J, Radicke S, Sack U, Himmerich H.

J Psychiatr Res. 2013 May;47(5):611-6. doi: 10.1016/j.jpsychires.2013.01.007. Epub 2013 Feb 6.

PMID:
23394815
2.

Depressive-like behavior induced by tumor necrosis factor-α in mice.

Kaster MP, Gadotti VM, Calixto JB, Santos AR, Rodrigues AL.

Neuropharmacology. 2012 Jan;62(1):419-26. doi: 10.1016/j.neuropharm.2011.08.018. Epub 2011 Aug 18.

PMID:
21867719
3.

Effects of long-term etanercept treatment on anxiety- and depression-like neurobehaviors in rats.

Bayramgürler D, Karson A, Ozer C, Utkan T.

Physiol Behav. 2013 Jul 2;119:145-8. doi: 10.1016/j.physbeh.2013.06.010. Epub 2013 Jun 13.

PMID:
23769689
4.

Depression-like deficits in rats improved by subchronic modafinil.

Regenthal R, Koch H, Köhler C, Preiss R, Krügel U.

Psychopharmacology (Berl). 2009 Jul;204(4):627-39. doi: 10.1007/s00213-009-1493-8. Epub 2009 Mar 3.

PMID:
19255746
5.

Effects of aspirin on immobile behavior and endocrine and immune changes in the forced swimming test: comparison to fluoxetine and imipramine.

Guan XT, Shao F, Xie X, Chen L, Wang W.

Pharmacol Biochem Behav. 2014 Sep;124:361-6. doi: 10.1016/j.pbb.2014.07.002. Epub 2014 Jul 12.

PMID:
25019653
6.

1,2,3,4-Tetrahydroisoquinoline produces an antidepressant-like effect in the forced swim test and chronic mild stress model of depression in the rat: Neurochemical correlates.

Możdżeń E, Papp M, Gruca P, Wąsik A, Romańska I, Michaluk J, Antkiewicz-Michaluk L.

Eur J Pharmacol. 2014 Apr 15;729:107-15. doi: 10.1016/j.ejphar.2014.01.075. Epub 2014 Feb 20.

PMID:
24561050
7.

Lipopolysaccharide repeated challenge followed by chronic mild stress protocol introduces a combined model of depression in rats: reversibility by imipramine and pentoxifylline.

Elgarf AS, Aboul-Fotouh S, Abd-Alkhalek HA, El Tabbal M, Hassan AN, Kassim SK, Hammouda GA, Farrag KA, Abdel-tawab AM.

Pharmacol Biochem Behav. 2014 Nov;126:152-62. doi: 10.1016/j.pbb.2014.09.014. Epub 2014 Sep 28.

PMID:
25268312
8.

Antidepressant-like effects of curcumin in chronic mild stress of rats: involvement of its anti-inflammatory action.

Jiang H, Wang Z, Wang Y, Xie K, Zhang Q, Luan Q, Chen W, Liu D.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Dec 2;47:33-9. doi: 10.1016/j.pnpbp.2013.07.009. Epub 2013 Jul 20.

PMID:
23876788
9.

Etanercept attenuates TNBS-induced experimental colitis: role of TNF-α expression.

Paiotti AP, Miszputen SJ, Oshima CT, Artigiani Neto R, Ribeiro DA, Franco M.

J Mol Histol. 2011 Oct;42(5):443-50. doi: 10.1007/s10735-011-9349-z. Epub 2011 Aug 24.

PMID:
21863329
10.
11.

Etanercept attenuates traumatic brain injury in rats by reducing early microglial expression of tumor necrosis factor-α.

Chio CC, Chang CH, Wang CC, Cheong CU, Chao CM, Cheng BC, Yang CZ, Chang CP.

BMC Neurosci. 2013 Mar 15;14:33. doi: 10.1186/1471-2202-14-33.

12.

Involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of tramadol in the rat forced swimming test.

Jesse CR, Bortolatto CF, Savegnago L, Rocha JB, Nogueira CW.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Dec 12;32(8):1838-43. doi: 10.1016/j.pnpbp.2008.08.010. Epub 2008 Aug 23.

PMID:
18773934
13.

The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf⁺/⁻ heterozygous null mice.

Lindholm JS, Autio H, Vesa L, Antila H, Lindemann L, Hoener MC, Skolnick P, Rantamäki T, Castrén E.

Neuropharmacology. 2012 Jan;62(1):391-7. doi: 10.1016/j.neuropharm.2011.08.015. Epub 2011 Aug 16.

PMID:
21867718
14.

Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression.

Wesołowska A, Nikiforuk A.

Neuropharmacology. 2007 Apr;52(5):1274-83. Epub 2007 Jan 20.

PMID:
17320917
15.

Depression-like behaviour in rats with mononeuropathy is reduced by the CB2-selective agonist GW405833.

Hu B, Doods H, Treede RD, Ceci A.

Pain. 2009 Jun;143(3):206-12. doi: 10.1016/j.pain.2009.02.018. Epub 2009 Apr 3.

PMID:
19345493
16.

Effect of etanercept, a tumor necrosis factor-alpha inhibitor, on neuropathic pain in the rat chronic constriction injury model.

Zanella JM, Burright EN, Hildebrand K, Hobot C, Cox M, Christoferson L, McKay WF.

Spine (Phila Pa 1976). 2008 Feb 1;33(3):227-34. doi: 10.1097/BRS.0b013e318162340a.

PMID:
18303453
17.

Immobility stress induces depression-like behavior in the forced swim test in mice: effect of magnesium and imipramine.

Poleszak E, Wlaź P, Kedzierska E, Nieoczym D, Wyska E, Szymura-Oleksiak J, Fidecka S, Radziwoń-Zaleska M, Nowak G.

Pharmacol Rep. 2006 Sep-Oct;58(5):746-52.

18.

SSR149415, a non-peptide vasopressin V1b receptor antagonist, has long-lasting antidepressant effects in the olfactory bulbectomy-induced hyperactivity depression model.

Breuer ME, van Gaalen MM, Wernet W, Claessens SE, Oosting RS, Behl B, Korte SM, Schoemaker H, Gross G, Olivier B, Groenink L.

Naunyn Schmiedebergs Arch Pharmacol. 2009 Jan;379(1):101-6. doi: 10.1007/s00210-008-0336-1. Epub 2008 Jul 31.

PMID:
18668225
19.

Randomized phase 2 trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis.

Marcora SM, Chester KR, Mittal G, Lemmey AB, Maddison PJ.

Am J Clin Nutr. 2006 Dec;84(6):1463-72.

20.

Chronic administration of infliximab (TNF-α inhibitor) decreases depression and anxiety-like behaviour in rat model of chronic mild stress.

Karson A, Demirtaş T, Bayramgürler D, Balci F, Utkan T.

Basic Clin Pharmacol Toxicol. 2013 May;112(5):335-40. doi: 10.1111/bcpt.12037. Epub 2013 Jan 19.

Supplemental Content

Support Center